Baillie Gifford - Scottish Mortgage Stock Stories - Illumina

Catharine Flood asks James Anderson how he identified the exceptional investment prospects for Illumina, and seeks his views on likely growth at the company as the cost of gene sequencing continues to fall, as well as at Illumina’s spin-off company Grail which is a trailblazer in liquid biopsy.